Angiotensin II and the vascular phenotype in hypertension.
about
A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzymeAnti-hypertensive Herbs and their Mechanisms of Action: Part IMechanisms of ectopic calcification: implications for diabetic vasculopathyRedox signaling, Nox5 and vascular remodeling in hypertensionArterial calcification in chronic kidney disease: key roles for calcium and phosphateSystemic and renal oxidative stress in the pathogenesis of hypertension: modulation of long-term control of arterial blood pressure by resveratrolAntioxidant-based therapies for angiotensin II-associated cardiovascular diseasesVascular biology of ageing-Implications in hypertensionThe role of Nrf2-mediated pathway in cardiac remodeling and heart failure.Neferine inhibits angiotensin II-induced rat aortic smooth muscle cell proliferation predominantly by downregulating fractalkine gene expressionCapitalizing on diversity: an integrative approach towards the multiplicity of cellular mechanisms underlying myogenic responsiveness.Anti-platelet therapy with clopidogrel prevents endothelial dysfunction and vascular remodeling in aortas from hypertensive rats.Surgical Treatment of Cervical Spondylotic Myelopathy Associated Hypertension--A Retrospective Study of 309 Patients.Alpha1a-Adrenoceptor Genetic Variant Triggers Vascular Smooth Muscle Cell Hyperproliferation and Agonist Induced Hypertrophy via EGFR Transactivation Pathway.Expression of Heat Shock Protein 70 Gene and Its Correlation with Inflammatory Markers in Essential HypertensionRelationship of inflammation and endothelial dysfunction with risks to cardiovascular disease among people in Inner Mongolia of China.Hypertensive Vasculopathy: An Exclusive Interview with Dr. Rhian M. Touyz, President of the International Society of HypertensionSoluble guanylyl cyclase is a target of angiotensin II-induced nitrosative stress in a hypertensive rat model.Population-based study of high plasma C-reactive protein concentrations among the Inuit of Nunavik.Transient Receptor Potential Melastatin 7 Cation Channel Kinase: New Player in Angiotensin II-Induced Hypertension.miR-155 functions downstream of angiotensin II receptor subtype 1 and calcineurin to regulate cardiac hypertrophy.Vascular calcification: pathophysiology and risk factorsAngiotensin receptor modulation and cardiovascular remodeling.Chronic kidney disease and vascular remodelling: molecular mechanisms and clinical implications.Ischemia and reactive oxygen species in sympathetic hyperactivity states: a vicious cycle that can be interrupted by renal denervation?Ectopic calcification in diabetic vascular disease.Blood pressure control versus atrial fibrillation management in stroke prevention.Protective role of dairy and its constituents on vascular function independent of blood pressure-lowering activities.Association of alpha-ADD1 Gene and Hypertension Risk: A Meta-Analysis.Hypoxia-inducible factor-1α in vascular smooth muscle regulates blood pressure homeostasis through a peroxisome proliferator-activated receptor-γ-angiotensin II receptor type 1 axis.Effects of a domain-selective ACE inhibitor in a mouse model of chronic angiotensin II-dependent hypertension.CO-releasing molecules CORM2 attenuates angiotensin II-induced human aortic smooth muscle cell migration through inhibition of ROS/IL-6 generation and matrix metalloproteinases-9 expression.Paraventricular Nucleus Infusion of Epigallocatechin-3-O-Gallate Improves Renovascular Hypertension.Personalized medicine-a modern approach for the diagnosis and management of hypertension.Effect of electroacupuncture stimulation on expression of angiotensinogen, angiotensin II type 1 receptor, endothelin-1, and endothelin a receptor mRNA in spontaneously hypertensive rat aorta.Vascular Smooth Muscle Contraction in Hypertension.Influence of atorvastatin on angiotensin I metabolism in resting and TNF-α -activated rat vascular smooth muscle cells.The direct renin inhibitor aliskiren improves vascular remodelling in transgenic rats harbouring human renin and angiotensinogen genesAngiotensin II upregulates cyclophilin A by enhancing ROS production in rat cardiomyocytes
P2860
Q24306614-6F3590AA-F055-4CD8-968C-41248E868A88Q26772791-3AEC772D-8F82-4ADB-B40B-30F1F220F6BEQ26778664-AE0DAC30-F06E-45FE-845E-C394A234A5DFQ26801400-5DA85A4F-F1AF-437D-AB2A-7D7914940477Q26827655-FB2FF2A3-9C47-4583-80A7-DAE0D5E3122FQ26999376-AF96A24F-60AC-4EE7-9EB4-3B631036D01DQ27016563-19E85B25-CDD3-4B19-8042-E45AF4BF7EF0Q28080862-94EBB7AD-F28E-452C-8017-CE6DDF1DB376Q33914944-C0F085FB-2120-49E2-B730-254DA22B8E78Q34292590-A0BD7667-9DCD-4FFF-A0D0-1DFEEF6C2923Q34488214-10D2F74D-A21B-4C18-AD4D-DD308A1A5B3AQ35123162-C4E5250A-7DFA-4527-BE8C-6A7FD66A5E51Q35699909-89541AAD-7C58-4090-9322-797559F2B895Q35842165-EAB93BA7-992B-47FE-8F6C-B59302AD6B75Q35962138-17E66255-E664-445F-B8B6-E55BC232EEC3Q36059027-F8AFE8EB-9BEE-4E07-BD47-6C2169168E67Q36283136-0D6309DF-5638-4736-AD42-9AAFAE987E34Q36309312-DFBB4901-6C9B-4BFB-897A-E82C5B3B6C9BQ36331913-D803A2EF-2D80-469F-B929-2DE8CC7E099BQ36673888-3D6ED9D2-91D4-4E48-8536-DE89B9BBBC90Q37204328-E5023191-6C9A-44CB-8FA7-4DFB96CE9764Q37649134-2374A8EE-1397-4894-8A16-76B732CD6848Q37924418-AF298DF8-C2C5-4587-BD0B-6D4DEF0544C0Q38016491-67614DB5-B0F9-42D6-ADB7-1E8DB985A3F5Q38113511-61CB4EA9-247A-4713-B9BA-B08FB300083BQ38193216-FCF8588E-A6B0-46FB-A9EA-457DD064326AQ38429854-5ABE4B06-CB2F-404E-9C3A-E92661DBE2E4Q38507394-325174A2-A25C-4D0C-A41E-63BBE29EE363Q38999538-8FC6BD4E-59B3-4BB4-BBCB-C8D7346BA3BBQ41908818-B154D678-1996-4A93-B3BC-C2E6C50D40C0Q42229346-F4C1B6BB-F788-41BA-BE67-1DC369E4DE1DQ42316580-C776FDF5-BEB9-4F9E-80F4-8F7EE6D3158DQ46702409-E2C42AC1-019F-47A3-A843-648DD94B80CFQ47095825-74EA6C77-ED67-4B4F-9E70-0906F2A0D2B3Q47409131-F097202C-1550-410E-8B80-876159983044Q50211596-6C943201-A739-46D6-95EE-AEB2D6CAD55BQ54272885-61F3F3D2-A438-489C-8641-F735439EF696Q56985191-3FE92D62-047A-4749-BD68-15034616C7D0Q58764102-03021D2A-C819-4A34-BD4D-F19A125CA4E9
P2860
Angiotensin II and the vascular phenotype in hypertension.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Angiotensin II and the vascular phenotype in hypertension.
@en
Angiotensin II and the vascular phenotype in hypertension.
@nl
type
label
Angiotensin II and the vascular phenotype in hypertension.
@en
Angiotensin II and the vascular phenotype in hypertension.
@nl
prefLabel
Angiotensin II and the vascular phenotype in hypertension.
@en
Angiotensin II and the vascular phenotype in hypertension.
@nl
P2860
P50
P1476
Angiotensin II and the vascular phenotype in hypertension.
@en
P2093
Nobu Nishigaki
P2860
P356
10.1017/S1462399411001815
P577
2011-03-30T00:00:00Z